{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T08:49:11Z","timestamp":1750150151580},"posted":{"date-parts":[[2023,10,3]]},"group-title":"In Review","reference-count":27,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p>Background\n Peptic ulcer disease (PUD) and Helicobacter pylori (HP) are associated with dyspepsia, but the role of gastric intestinal metaplasia (IM) has not been described. The objective of this study is to examine the association between gastric IM and dyspepsia.\nMethods\n We developed a cohort of consecutive patients referred to gastroenterology between Jan 2019 and July 2020 for dyspepsia and iron deficiency anemia (IDA) and completed an upper endoscopy with biopsies in a safety-net health system. The primary outcome was the prevalence of gastric IM in patients with dyspepsia compared to IDA. Secondary outcomes included prevalence of HP, chronic gastritis (CG) and chronic active gastritis (CAG) in the dyspepsia and IDA groups. A multivariable analysis was performed to assess the independent association between gastric IM and dyspepsia\nResults:\n Compared to the IDA cohort (n\u2009=\u2009366), patients with dyspepsia (n\u2009=\u2009349) were more likely to be female (65% vs. 47%, p\u2009&lt;\u20090.01), harbor gastric IM (20.3% vs. 14.2%, p\u2009=\u20090.03), and less likely to have CAG (12.0% vs. 26.5%, p\u2009&lt;\u20090.01) or HP (10.9% vs. 21.3%, p\u2009&lt;\u20090.01). After adjusting for pathological findings, race, ethnicity, gender and age, the association strengthened between IM and dyspepsia (adj OR 1.81 from OR 1.54, 95% CI 1.19\u20132.76, p\u2009&lt;\u20090.01).\nConclusions:\n We observed a significant relationship between the presence of gastric IM and dyspepsia symptoms, which increased after adjusting for confounding factors. Future studies should verify the relationship between IM and dyspepsia, the effect of IM regression, and possible mediators of gastric IM on symptoms.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3335631\/v1","type":"posted-content","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:49:26Z","timestamp":1696319366000},"source":"Crossref","is-referenced-by-count":1,"title":["Intestinal Metaplasia Associated with Symptoms of Dyspepsia"],"prefix":"10.21203","author":[{"given":"Omar","family":"Viramontes","sequence":"first","affiliation":[{"name":"University of California, Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Martinez","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Somsouk","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel RL","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/j.gastro.2015.07.039","article-title":"American Gastroenterological Association Institute Guideline on the Role of Upper Gastrointestinal Biopsy to Evaluate Dyspepsia in the Adult Patient in the Absence of Visible Mucosal Lesions","volume":"149","author":"Yang YX","year":"2015","unstructured":"Yang YX, et al. American Gastroenterological Association Institute Guideline on the Role of Upper Gastrointestinal Biopsy to Evaluate Dyspepsia in the Adult Patient in the Absence of Visible Mucosal Lesions. Gastroenterology. 2015;149(4):1082\u20137.","journal-title":"Gastroenterology"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","volume":"150","author":"Stanghellini V","year":"2016","unstructured":"Stanghellini V, et al. Gastroduodenal Disorders Gastroenterology. 2016;150(6):1380\u201392.","journal-title":"Gastroduodenal Disorders Gastroenterology"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0016-5085(98)70542-6","article-title":"AGA technical review: evaluation of dyspepsia. American Gastroenterological Association","volume":"114","author":"Talley NJ","year":"1998","unstructured":"Talley NJ, et al. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology. 1998;114(3):582\u201395.","journal-title":"Gastroenterology"},{"issue":"20","key":"ref6","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3748\/wjg.v16.i20.2520","article-title":"Rate and yield of repeat upper endoscopy in patients with dyspepsia","volume":"16","author":"Ladabaum U","year":"2010","unstructured":"Ladabaum U, Dinh V. Rate and yield of repeat upper endoscopy in patients with dyspepsia. World J Gastroenterol. 2010;16(20):2520\u20135.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"ref7","first-page":"92","article-title":"Overview of Current Concepts in Gastric Intestinal Metaplasia and Gastric Cancer","volume":"14","author":"Jencks DS","year":"2018","unstructured":"Jencks DS, et al. Overview of Current Concepts in Gastric Intestinal Metaplasia and Gastric Cancer. Gastroenterol Hepatol (N Y). 2018;14(2):92\u2013101.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG Clinical Guideline: Management of Dyspepsia","volume":"112","author":"Moayyedi P","year":"2017","unstructured":"Moayyedi P, et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017;112(7):988\u20131013.","journal-title":"Am J Gastroenterol"},{"key":"ref9","volume-title":"The Fear of Gastric Cancer in Patients with Dyspepsia: Challenge in Specialist Care Gastroenterology","author":"Macke L","year":"2021","unstructured":"Macke L, Schulz C, Malfertheiner P. The Fear of Gastric Cancer in Patients with Dyspepsia: Challenge in Specialist Care Gastroenterology. Digestive Diseases; 2021."},{"issue":"3","key":"ref10","first-page":"584","article-title":"[Iron deficiency anemia and H. pylori]","volume":"66","author":"Shimada T","year":"2008","unstructured":"Shimada T, Hiraishi H. [Iron deficiency anemia and H. pylori]. Nihon Rinsho. 2008;66(3):584\u20139.","journal-title":"Nihon Rinsho"},{"issue":"3","key":"ref11","first-page":"245","article-title":"Efficacy of narrow-band imaging for detecting intestinal metaplasia in adult patients with symptoms of dyspepsia","volume":"83","author":"Sobrino-Coss\u00edo S","year":"2018","unstructured":"Sobrino-Coss\u00edo S, et al. Efficacy of narrow-band imaging for detecting intestinal metaplasia in adult patients with symptoms of dyspepsia. Rev Gastroenterol Mex (Engl Ed). 2018;83(3):245\u201352.","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.7314\/APJCP.2013.14.6.3549","article-title":"Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran","volume":"14","author":"Mansour-Ghanaei F","year":"2013","unstructured":"Mansour-Ghanaei F, et al. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran. Asian Pac J Cancer Prev. 2013;14(6):3549\u201354.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref13","author":"Buran T","year":"2021","unstructured":"Buran T, Kasap, Elmas, Ayhan S. Does the Location and Prevelance of Gastric Intestinal Metaplasia Change in Patients with Functional Dyspepsia. 2021, Open Access Library Journal: Scientific Research."},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/gut.33.1.16","article-title":"Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum","volume":"33","author":"Craanen ME","year":"1992","unstructured":"Craanen ME, et al. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992;33(1):16\u201320.","journal-title":"Gut"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/00365529409092480","article-title":"Prevalence of intestinal metaplasia in Helicobacter pylori gastritis","volume":"29","author":"Eidt S","year":"1994","unstructured":"Eidt S, Stolte M. Prevalence of intestinal metaplasia in Helicobacter pylori gastritis. Scand J Gastroenterol. 1994;29(7):607\u201310.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/003655202317284156","article-title":"Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis","volume":"37","author":"Petersson F","year":"2002","unstructured":"Petersson F, Borch K, Franz\u00e9n LE. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol. 2002;37(3):262\u20136.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jcp.57.1.37","article-title":"Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran","volume":"57","author":"Malekzadeh R","year":"2004","unstructured":"Malekzadeh R, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004;57(1):37\u201342.","journal-title":"J Clin Pathol"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","DOI":"10.1157\/13123970","article-title":"Systematic review of the prevalence of gastric intestinal metaplasia and its area-level association with smoking","volume":"22","author":"Peleteiro B","year":"2008","unstructured":"Peleteiro B et al. Systematic review of the prevalence of gastric intestinal metaplasia and its area-level association with smoking. Gac Sanit, 2008. 22(3): p. 236 \u2013 47; discussion 246-7.","journal-title":"Gac Sanit"},{"issue":"4","key":"ref19","first-page":"293","article-title":"Gastric intestinal metaplasia in ethnic groups in the southwestern United States","volume":"1","author":"Fennerty MB","year":"1992","unstructured":"Fennerty MB, et al. Gastric intestinal metaplasia in ethnic groups in the southwestern United States. Cancer Epidemiol Biomarkers Prev. 1992;1(4):293\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cgh.2016.05.045","article-title":"Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System","volume":"14","author":"Reddy KM","year":"2016","unstructured":"Reddy KM, et al. Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System. Clin Gastroenterol Hepatol. 2016;14(10):1420\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4251\/wjgo.v4.i3.30","article-title":"Follow-up of intestinal metaplasia in the stomach: When, how and why","volume":"4","author":"Zullo A","year":"2012","unstructured":"Zullo A, et al. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol. 2012;4(3):30\u20136.","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gutjnl-2017-314498","article-title":"Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions","volume":"68","author":"Hollander WJ","year":"2019","unstructured":"den Hollander WJ, et al. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut. 2019;68(4):585\u201393.","journal-title":"Gut"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"e0255601","DOI":"10.1371\/journal.pone.0255601","article-title":"Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial)","volume":"16","author":"Aumpan N","year":"2021","unstructured":"Aumpan N, et al. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS ONE. 2021;16(8):e0255601.","journal-title":"PLoS ONE"},{"key":"ref24","author":"Al Hennawi H","year":"2021","unstructured":"Al Hennawi H, Maan KA et al. R K,., Gastric Intestinal Metaplasia and Its Rapid Progression Toward Gastric Adenocarcinoma: A Call for Clear Patient Management and Awareness. 2021, Cureus 13(10)."},{"issue":"3","key":"ref25","first-page":"178","article-title":"H.pylori associated with iron deficiency anemia even in celiac disease patients; strongly evidence based but weakly reflected in practice","volume":"8","author":"Rostami-Nejad M","year":"2015","unstructured":"Rostami-Nejad M, et al. H.pylori associated with iron deficiency anemia even in celiac disease patients; strongly evidence based but weakly reflected in practice. Gastroenterol Hepatol Bed Bench. 2015;8(3):178\u201382.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jgh3.12318","article-title":"Novel treatment for gastric intestinal metaplasia, a precursor to cancer","volume":"4","author":"Lam SK","year":"2020","unstructured":"Lam SK, Lau G. Novel treatment for gastric intestinal metaplasia, a precursor to cancer. JGH Open. 2020;4(4):569\u201373.","journal-title":"JGH Open"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.52.1.1","article-title":"Is intestinal metaplasia of the stomach reversible?","volume":"52","author":"Walker MM","year":"2003","unstructured":"Walker MM. Is intestinal metaplasia of the stomach reversible? Gut. 2003;52(1):1\u20134.","journal-title":"Gut"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3335631\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3335631\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T05:15:01Z","timestamp":1702271701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3335631\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":27,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3335631\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,10,3]]},"subtype":"preprint"}}